Moloud Alsadat Mousavi

Moloud Alsadat Mousavi

Auto-generated profile, based on publicly available information

Moloud Alsadat Mousavi

Department of Gynecology and Obstetrics, Imam Hossein Hospital, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2024 in Immunopathologia Persa
Verified
Journal Article
Open access
PDF file
SASheida Abbasi
Sheida Abbasi
JRJalal Rezaei
Jalal Rezaei
FBFariba Bazi
Fariba Bazi
MMMoloud Alsadat Mousavi
Moloud Alsadat Mousavi
SRSadaf Rassouli
Sadaf Rassouli
ZMZahra Hamidi Madani
Zahra Hamidi Madani
Introduction: Endometrial cancer is one of the most prevalent female malignancies, with various factors, including metabolic syndrome, contributing to its incidence. Thus, this study aims to evaluate the association between metabolic syndrome and the risk of endometrial carcinoma. Materials and Methods: In this systematic review and meta-analysis, two independent authors searched electronic databases, including Cochrane, PubMed, ProQuest, Web of Science, and the Google Scholar search engine up to May 16, 2024. Data analysis was conducted using STATA 14 software with a significance level of P < 0.05 for all tests. Results: A pooled analysis of 12 observational studies found that metabolic syndrome elevated the risk of endometrial carcinoma by 37% overall (OR: 1.37, 95% CI: 1.33, 1.42), 35% in cohort studies (OR: 1.35, 95% CI: 1.29, 1.42), and 40% in case-control studies (OR: 1.40, 95% CI: 1.33, 1.48). However, hypertension increased the risk of endometrial carcinoma by 25% (OR: 1.25, 95% CI: 1.18, 1.33), fasting hyperglycemia by 25% (OR: 1.25, 95% CI: 1.15, 1.37), hypertriglyceridemia by 17% (OR: 1.17, 95% CI: 1.13, 1.21), low high density lipoprotein (HDL) by 20% (OR:1.20, 95% CI: 1.12, 1.28), increased waist circumference by 59% (OR:1.59, 95% CI: 1.43, 1.77), pre-menopausal period by 67% (OR:1.67, 95% CI: 1.38, 2.02), and post-menopausal period by 61% (OR: 1.61, 95% CI: 1.17, 2.21). Likewise, obesity almost doubled the risk of endometrial carcinoma (OR: 2.13, 95% CI: 1.65, 2.75). Conclusion: Metabolic syndrome increases the risk of endometrial carcinoma, with obesity being the most dangerous risk factor for endometrial cancer. Thus, managing metabolic disorders in women can be an important step toward reducing the incidence of endometrial cancer. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD42024551509) and Research Registry (UIN: reviewregistry1838).

22 August 2023 in Immunopathologia Persa
Verified
Journal Article
Open access
JSJavad Sadeghi
Javad Sadeghi
SBSaba Bazzazi
Saba Bazzazi
FFFarinaz Fattahi
Farinaz Fattahi
MMMoloud Alsadat Mousavi
Moloud Alsadat Mousavi
ATArdeshir Tajbakhsh
Ardeshir Tajbakhsh
AGAnna Ghorbani
Anna Ghorbani
Introduction: Ovarian cancer is the sixth leading cancer-related mortality cause in women worldwide. Analgesics may hinder the occurrence of ovarian cancer through inflammation relief. The present study seeks to examine the relationship between analgesic consumption and ovarian cancer risk through a systematic review and meta-analysis. Materials and Methods: PubMed, Scopus, Web of Science, Cochrane databases, and Google Scholar search engines were searched for works published by May 2023 using standard keywords to collect the required data sources. Acquired data were then analyzed in STATA version14, considering a significance level of P < 0.05 in statistical tests. Results: The present meta-analysis comprised 21 studies (14 case-control and 7 cohort studies) performed on 53,755 subjects. Results indicated that taking aspirin reduced the risk of ovarian cancer by 8% (OR: 0.92; 95% CI: 0.87, 0.98), whereas other non-aspirin NSAIDs (non-steroidal anti-inflammatory drugs) did not significantly affect the ovarian cancer risk (OR: 0.91; 95% CI: 0.81, 1.02). Similar results were observed in the case of ibuprofen and acetaminophen, with non-significant relationships between the risk of ovarian cancer and with the consumption of both acetaminophen (OR: 0.95; 95% CI: 0.84, 1.08) and ibuprofen (OR: 0.76; 95% CI: 0.50, 1.14). Furthermore, the duration of analgesic consumption was not significantly linked to the risk of ovarian cancer in the case of all studied drugs. Conclusion: Among aspirin, ibuprofen, acetaminophen, and non-aspirin NSAIDs, only aspirin was found to reduce the risk of ovarian cancer in women while the other studied drugs did not influence the studied risk. However, further research is recommended to confirm the results. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (CRD42023434730) and Research Registry (UIN: reviewregistry1668) websites.

1 January 2024 in Journal of Renal Endocrinology
Verified
Journal Article
Open access
PDF file
MMMoloud Alsadat Mousavi
Moloud Alsadat Mousavi
MHMehdi Hosseinifard
Mehdi Hosseinifard
MAMaryam Aligholizadeh
Maryam Aligholizadeh
SSSiavash Sangi
Siavash Sangi
ZKZahra Kordeyazdi
Zahra Kordeyazdi
FZFaraz Zandiyeh
Faraz Zandiyeh
Vitamin D is crucial for maintaining optimal health. This review study evaluates health problems related to deficiency and ways to maintain sufficient levels. We conducted a review of the association between vitamin D inadequacy and various diseases, explored the various sources of vitamin D and the risk factors associated with vitamin D insufficiency, examined the consequences of insufficient vitamin D levels, and assessed the potential benefits of taking vitamin D supplements for promoting good health. A literature review demonstrated that maintaining sufficient levels of vitamin D is essential for improving health and preventing various diseases. Vitamin D deficiency is a common condition, and it can be addressed by consuming a balanced diet, getting regular exposure to sunlight, or taking supplements as necessary.